Abstract
Metastases in breast cancer are a vital concern in treatment, with epidermal growth factor receptor and ErbB2 strongly implicated in mediating tumor invasion and spreading. In this study, we investigated the role of decorin in suppressing both primary breast carcinomas and pulmonary metastases. We show that decorin causes marked growth suppression both in vitro and in vivo using a metastatic breast cancer cell line and an orthotopic mammary carcinoma model. Treatment with decorin protein core reduced primary tumor growth by 70% and eliminated observed metastases. An adenoviral vector containing the decorin transgene caused primary tumor retardation of 70%, in addition to greatly reducing observed metastases. Moreover, we demonstrate that ErbB2 phosphorylation and total receptor protein levels are reduced in this model system upon de novo expression of decorin under the control of a doxycycline-inducible promoter. Primary tumor growth in vivo was reduced by up to 67% upon decorin induction, and pulmonary metastases were markedly hampered as well. These effects are likely occurring through decorin's long-term downregulation of the ErbB2 tyrosine kinase cascade. These results demonstrate a novel role for decorin in reduction or prevention of tumor metastases in this breast cancer model and could eventually lead to improved therapeutics for metastatic breast cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- Ad-Dcn:
-
adenovirus-decorin
- EGFR:
-
epidermal growth factor receptor
- PFU:
-
plaque-forming units
- HRP:
-
horseradish peroxidase
References
Adany R, Heimer R, Caterson B, Sorrell JM and Iozzo RV . (1990). J. Biol. Chem., 265, 11389–11396.
Ahmed F, Wyckoff J, Lin EY, Wang W, Wang Y, Hennighausen L, Miyazaki J, Jones J, Pollard JW, Condeelis JS and Segall JE . (2002). Cancer Res., 62, 7166–7169.
Carpenter G . (2000). BioEssays, 22, 697–707.
Csordás G, Santra M, Reed CC, Eichstetter I, McQuillan DJ, Gross D, Nugent MA, Hajnóczky G and Iozzo RV . (2000). J. Biol. Chem., 275, 32879–32887.
de Lange Davies C, Melder RJ, Munn LL, Mouta-Carreira C, Jain RK and Boucher Y . (2001). Microvasc. Res., 62, 26–42.
Goldoni S, Owens RT, McQuillan DJ, Shriver Z, Sasisekharan R, Birk DE, Campbell S and Iozzo RV . (2004). J. Biol. Chem., 279, 6606–6612.
Gossen M and Bujard H . (1992). Proc. Natl. Acad. Sci. USA, 89, 5547–5551.
Grant DS, Yenisey C, Rose RW, Tootell M, Santra M and Iozzo RV . (2002). Oncogene, 21, 4765–4777.
Iozzo RV . (1998). Annu. Rev. Biochem., 67, 609–652.
Iozzo RV . (1999). J. Biol. Chem., 274, 18843–18846.
Iozzo RV, Chakrani F, Perrotti D, McQuillan DJ, Skorski T, Calabretta B and Eichstetter I . (1999a). Proc. Natl. Acad. Sci. USA, 96, 3092–3097.
Iozzo RV, Moscatello D, McQuillan DJ and Eichstetter I . (1999b). J. Biol. Chem., 274, 4489–4492.
Koninger J, Giese NA, di Mola FF, Berberat P, Giese T, Esposito I, Bachem MG, Buchler MW and Friess H . (2004). Clin. Cancer Res., 10, 4776–4783.
Mendelsohn J and Baselga J . (2000). Oncogene, 19, 6550–6565.
Moscatello DK, Santra M, Mann DM, McQuillan DJ, Wong AJ and Iozzo RV . (1998). J. Clin. Invest., 101, 406–412.
Nash MA, Deavers MT and Freedman RS . (2002). Clin. Cancer Res., 8, 1754–1760.
Nash MA, Loercher AE and Freedman RS . (1999). Cancer Res., 59, 6192–6196.
Neri A, Welch D, Kawaguchi T and Nicholson GL . (1982). J. Natl. Cancer Inst., 68, 507–517.
Ramamurthy P, Hocking AM and McQuillan DJ . (1996). J. Biol. Chem., 271, 19578–19584.
Reed CC, Gauldie J and Iozzo RV . (2002). Oncogene, 21, 3688–3695.
Reed CC and Iozzo RV . (2003). Glycoconjugate J., 19, 249–255.
Santra M, Eichstetter I and Iozzo RV . (2000). J. Biol. Chem., 275, 35153–35161.
Santra M, Mann DM, Mercer EW, Skorski T, Calabretta B and Iozzo RV . (1997). J. Clin. Invest., 100, 149–157.
Santra M, Reed CC and Iozzo RV . (2002). J. Biol. Chem., 277, 35671–35681.
Santra M, Skorski T, Calabretta B, Lattime EC and Iozzo RV . (1995). Proc. Natl. Acad. Sci. USA, 92, 7016–7020.
Schönherr E, Levkau B, Schaefer L, Kresse H and Walsh K . (2001). J. Biol. Chem., 276, 40687–40692.
Tralhão JG, Schaefer L, Micegova M, Evaristo C, Schönherr E, Kayal S, Veiga-Fernandes H, Danel C, Iozzo RV, Kresse H and Lemarchand P . (2003). FASEB J., 17, 464–466.
Troup S, Njue C, Kliewer EV, Parisien M, Roskelley C, Chakravarti S, Roughley PJ, Murphy LC and Watson PH . (2003). Clin. Cancer Res., 9, 207–214.
Verbeek BS, Adriaansen-Slot SS, Vroom TM, Beckers T and Rijksen G . (1998). FEBS Lett., 425, 145–150.
Wang W, Wyckoff JB, Frohlich VC, Oleynikov Y, Hüttelmaier S, Zavadil J, Cermak L, Bottinger EP, Singer RH, White JG, Segall JE and Condeelis JS . (2002). Cancer Res., 62, 6278–6288.
Wyckoff JB, Jones JG, Condeelis JS and Segall JE . (2000). Cancer Res., 60, 2504–2511.
Xaus J, Comalada M, Cardó M, Valledor AF and Celada A . (2001). Blood, 98, 2124–2133.
Yamaguchi Y, Mann DM and Ruoslahti E . (1990). Nature, 346, 281–284.
Acknowledgements
We thank JE Segall for providing the MTLn3 cells, and J Gauldie for the Ad-Decorin vector. This work was supported by grants from the National Institutes of Health RO1 CA39481 and RO1 CA47282, and a grant from the Department of the Army DAMD17-00-1-0425 to RV Iozzo.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reed, C., Waterhouse, A., Kirby, S. et al. Decorin prevents metastatic spreading of breast cancer. Oncogene 24, 1104–1110 (2005). https://doi.org/10.1038/sj.onc.1208329
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208329
Keywords
This article is cited by
Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia
Nature Communications (2021)
Decorin gene upregulation mediated by an adeno-associated virus vector increases intratumoral uptake of nab-paclitaxel in neuroblastoma via inhibition of stabilin-1
Investigational New Drugs (2017)
Mechanistic and therapeutic overview of glycosaminoglycans: the unsung heroes of biomolecular signaling
Glycoconjugate Journal (2016)
Effects of promoter leakage on dynamics of gene expression
BMC Systems Biology (2015)
Extracellular matrix macromolecules: potential tools and targets in cancer gene therapy
Molecular and Cellular Therapies (2014)